Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium

Targeting Translation and the Cell Cycle Inversely Affects CTC Metabolism but Not Metastasis

DanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts

Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping

Analytical performance of the FDA-cleared Parsortix®PC1 system

Association of Circulating Tumor Cells, Megakaryocytes and a High Immune-Inflammatory Environment in Metastatic Breast Cancer

Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer

Comparative evaluation of PD-L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non-small cell lung cancer patients

The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients

The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer

Request a meeting with